Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 7, 2015
[ Wed, Oct 07th 2015
] - WOPRAI
Tue, October 6, 2015
[ Tue, Oct 06th 2015
] - WOPRAI
[ Tue, Oct 06th 2015
] - WOPRAI
[ Tue, Oct 06th 2015
] - WOPRAI
[ Tue, Oct 06th 2015
] - WOPRAI
[ Tue, Oct 06th 2015
] - WOPRAI
Mon, October 5, 2015
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
[ Mon, Oct 05th 2015
] - WOPRAI
Fri, October 2, 2015
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
Matthew Harrison Upgraded (VRTX) to Buy and Increased Target to $148 on, Oct 2nd, 2015
Matthew Harrison of Morgan Stanley, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Increased Target from $118 to $148 on, Oct 2nd, 2015.
Matthew has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
- Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $133 on, Monday, July 6th, 2015
These are the ratings of the 2 analyists that currently disagree with Matthew
- Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015
- Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $148 on, Thursday, July 30th, 2015
